Canada Life’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44K | Buy |
12,190
+2,756
| +29% | +$11K | ﹤0.01% | 1772 |
|
|
2025
Q4 | $33K | Buy |
9,434
+1,808
| +24% | +$6.19K | ﹤0.01% | 1823 |
|
|
2025
Q3 | $25K | Sell |
7,626
-4,576
| -38% | -$14.4K | ﹤0.01% | 1866 |
|
|
2025
Q2 | $29K | Buy |
12,202
+5,926
| +94% | +$30K | ﹤0.01% | 1868 |
|
|
2025
Q1 | $42K | Hold |
6,276
| – | – | ﹤0.01% | 1879 |
|
|
2024
Q4 | $79K | Hold |
6,276
| – | – | ﹤0.01% | 1848 |
|
|
2024
Q3 | $116K | Hold |
6,276
| – | – | ﹤0.01% | 1841 |
|
|
2024
Q2 | $135K | Hold |
6,276
| – | – | ﹤0.01% | 1844 |
|
|
2024
Q1 | $169K | Hold |
6,276
| – | – | ﹤0.01% | 1858 |
|
|
2023
Q4 | $187K | Buy |
6,276
+1,289
| +26% | +$28.4K | ﹤0.01% | 1852 |
|
|
2023
Q3 | $102K | Buy |
4,987
+3,368
| +208% | +$61.2K | ﹤0.01% | 1957 |
|
|
2023
Q2 | $32K | Sell |
1,619
-1,302
| -45% | -$26.3K | ﹤0.01% | 2062 |
|
|
2023
Q1 | $50K | Hold |
2,921
| – | – | ﹤0.01% | 2067 |
|
|
2022
Q4 | $57K | Buy |
2,921
+427
| +17% | +$7.86K | ﹤0.01% | 2061 |
|
|
2022
Q3 | $40K | Buy |
2,494
+117
| +5% | +$1.83K | ﹤0.01% | 2138 |
|
|
2022
Q2 | $32K | Buy |
2,377
+108
| +5% | +$1.29K | ﹤0.01% | 2160 |
|
|
2022
Q1 | $39K | Buy |
2,269
+112
| +5% | +$1.94K | ﹤0.01% | 2218 |
|
|
2021
Q4 | $47K | Buy |
2,157
+105
| +5% | +$2.86K | ﹤0.01% | 2190 |
|
|
2021
Q3 | $62K | Hold |
2,052
| – | – | ﹤0.01% | 2176 |
|
|
2021
Q2 | $91K | Hold |
2,052
| – | – | ﹤0.01% | 2113 |
|
|
2021
Q1 | $90K | Hold |
2,052
| – | – | ﹤0.01% | 2129 |
|
|
2020
Q4 | $112K | Hold |
2,052
| – | – | ﹤0.01% | 2090 |
|
|
2020
Q3 | $47K | Hold |
2,052
| – | – | ﹤0.01% | 2196 |
|
|
2020
Q2 | $43K | Hold |
2,052
| – | – | ﹤0.01% | 2264 |
|
|
2020
Q1 | $29K | Hold |
2,052
| – | – | ﹤0.01% | 2290 |
|
|
2019
Q4 | $46K | Buy |
+2,052
| New | +$34.3K | ﹤0.01% | 2292 |
|
|
2019
Q3 | – | Sell |
-3,868
| Closed | -$58K | – | 2009 |
|
|
2019
Q2 | $58K | Hold |
3,868
| – | – | ﹤0.01% | 2406 |
|
|
2019
Q1 | $67K | Hold |
3,868
| – | – | ﹤0.01% | 2188 |
|
|
2018
Q4 | $55K | Hold |
3,868
| – | – | ﹤0.01% | 2337 |
|
|
2018
Q3 | $95K | Hold |
3,868
| – | – | ﹤0.01% | 2208 |
|
|
2018
Q2 | $76K | Buy |
+3,868
| New | +$73.2K | ﹤0.01% | 2290 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
Canada Life's RCKT Position: Q1 2026 in Review
Canada Life increased its Rocket Pharmaceuticals (RCKT) stake by 29% in Q1 2026, buying an estimated $11K and bringing the position to 12,190 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.
Canada Life first reported a position in RCKT in Q2 2018 and has held it in 31 quarters since. The position peaked at $187K in Q4 2023. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.
- Canada Life held 12,190 shares of Rocket Pharmaceuticals worth $44K as of Q1 2026.
- Canada Life bought 2,756 Rocket Pharmaceuticals shares in Q1 2026, an estimated $11K.
- Rocket Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1772 holding.
- Canada Life first reported a position in Rocket Pharmaceuticals in Q2 2018 and has held it in 31 quarters since.
- Canada Life's Rocket Pharmaceuticals position peaked at $187K in Q4 2023.
- 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.